Clinical Trials Browser

Skin Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms, Liver Neoplasms

Carcinoma, Hepatocellular

Advanced Pancreatic Cancer

Brain Neoplasms

Small Cell Lung Carcinoma

Advanced Solid Tumor

Colorectal Neoplasms

Mouth Neoplasms

Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung, Melanoma

Primary Condition: Advanced Tumors

High-Risk Resectable NSCLC

Advanced Solid Tumors

Nasopharyngeal Carcinoma

Advanced Tumors

Advanced Cervical Cancer

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma

Squamous Cell Carcinoma of Head and Neck

Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Melanoma, Neoplasm Metastasis

Lung Neoplasms, Lymphoma

Clinical Trials

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung Cancer

A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor

Combination Therapy for First Line Treatment of Advanced Cervical Cancer

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer

Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer

Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors